FDA Clears Inari Medical FlowTriever System for Treatment of Right Atrial Clot in Transit
510(k) clearance allows retrieval of life-threatening DVT thrombus that has migrated to the heart
The FDA has granted 510(k) clearance for the Inari Medical Inc. FlowTriever system for the treatment of clot in transit (CIT) in the right atrium. FlowTriever is the first thrombectomy system not requiring a cardiopulmonary bypass circuit to be FDA cleared for blood clots in the right atrium.
January 8, 2021 The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Inari Medical Inc. FlowTriever system for the treatment of clot in transit (CIT) in the right atrium.